Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
InveniAI® LLC, has announced the appointment of Salvatore (Salvo) Alesci, M.D., Ph.D., as its Chief Scientific Officer.
read more
InveniAI® LLC has announced a multi-target drug discovery collaboration with Shionogi & Co., Ltd.
read more
Intravacc and Versatope have signed a research service agreement to further develop a universal vaccine against influenza based on Intravacc’s OMV technology.
read more
Monday, February 22, 2021
Intravacc announced its new modern pilot production plant will soon be operational.
read more
Wednesday, September 09, 2020
Intravacc has been awarded a contract with base and options that may total US$9.4 million from the NIAID for the development of a prophylactic vaccine against enterovirus D68.
read more
Thursday, January 21, 2021
Intravacc announced a candidate polyvalent inactivated coxsackievirus B vaccine it developed and manufactured for Provention Bio has entered into a first in human Phase I clinical study.
read more
Intravacc, has been awarded a contract with base and options that may total US$14.6 million from the US National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for the development of a ...
read more
Intravacc and Celonic have signed a research agreement to further design, develop and produce a Covid-19 vaccine.
read more
Wednesday, September 23, 2015
Intertek has opened a 10,000 ft² bioanalytical and biopharmaceutical characterization facility to deliver world-class scientific services to support the growing pipeline of biologics medicines such as monoclonal antibodies currently in development by...
read more
Tuesday, October 20, 2015
Intertek has formally launched the expanded GLP Bioanalytical Centre of Excellence in San Diego, California, USA to deliver world-class bioanalysis
read more
Intertek, the leading quality solutions provider to industries worldwide, announces that it has acquired Melbourn Scientific Ltd (“Melbourn”), a leading provider of analysis and development services for the pharmaceutical, biopharmaceutical, ...
read more
Wednesday, March 11, 2020
International Pharmaceutical Expo (INTERPHEX) will be postponed due to the COVID-19 virus.
read more
INTERPHEX, American Pharmaceutical Review, and Pharmaceutical Outsourcing announced the winners of the 2020 INTERPHEX Exhibitor Awards.
read more
International Pharmaceutical Expo (INTERPHEX) has announced the next edition of INTERPHEX, previously postponed to July 2020, will now take place April 20-22, 2021 at the Javits Center in New York. The 2020 dates are cancelled.
read more
International Process Plants (IPP) announced its subsidiary Humber Industrials Ltd. has reached an agreement to purchase Novartis UK's 170-acre active pharmaceutical ingredient (API) manufacturing plant site and assets in Grimsby, UK.
read more